Skip to main content

These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say

DexCom could be the first stock to break out of ‘GLP jail,’ analysts say, as market continues to punish device makers
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.